XML 20 R33.htm IDEA: XBRL DOCUMENT

Note 10 - Segment Information (Tables)

9 Months Ended

Sep. 30, 2014

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Three Months Ended September 30,						Nine Months Ended September 30,
	2014			2013			2014			2013
Revenues:
Prescription Pharmaceuticals	$	120,022		$	72,677		$	338,101		$	205,185
Consumer Health		12,710			9,215			36,002			27,573

Total revenues		132,732			81,892			374,103			232,758

Gross Profit:
Prescription Pharmaceuticals		45,524			38,372			158,820			109,138
Consumer Health		6,210			5,325			19,241			15,796

Total gross profit		51,734			43,697			178,061			124,934

Operating expenses		57,776			21,509			144,400			61,906

Operating income (loss)		(6,042	)		22,188			33,661			63,028
Other (expense)		(12,497	)		(2,206	)		(22,196	)		(6,807	)

Income (loss) from continuing operations before income taxes	$	(18,539	)	$	19,982		$	11,465		$	56,221

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details